Epidemiological investigations have confirmed that breast cancer tumors in women with low circulating adiponectin levels exhibit more aggressive characteristics, such as higher histological grade and enhanced angiogenesis and metastasis [67]. Here, ADIPOQ is linked to breast cancer.